Search company, investor...

BioInvent International

Founded Year

1996

Stage

IPO | IPO

Total Raised

$29.66M

Date of IPO

6/12/2001

About BioInvent International

Manufacturer of protein-based drugs. The company offers large-scale contract manufacturing of antibodies and other mammalian cell-derived proteins. Therapeutic- or diagnostic-grade products are produced in a GMP-certified facility based on a continuous perfusion culture system to comply with FDA and EU regulations.

Headquarters Location

Soelvegatan 41

Lund, SE-223 70,

Sweden

46 462868550

Loading...

Loading...

BioInvent International Patents

BioInvent International has filed 23 patents.

The 3 most popular patent topics include:

  • clusters of differentiation
  • immune system
  • immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/22/2020

5/16/2023

G protein coupled receptors, Hepatology, Transcription factors, Clusters of differentiation, Oncology

Grant

Application Date

7/22/2020

Grant Date

5/16/2023

Title

Related Topics

G protein coupled receptors, Hepatology, Transcription factors, Clusters of differentiation, Oncology

Status

Grant

Latest BioInvent International News

BioInvent regains rights to immuno-oncology targets from Exelixis

Jan 12, 2024

12-01-2024 After an initial dip, BioInvent International (Nasdaq Stockholm: BINV) saw its shares close up 1.2% at 17.22 kronor today, when the Swedish biotech revealed that a licensing partner was pulling out of their agreement. BioInvent said it has received a notice of termination from US biotech company Exelixis (Nasdaq: EXEL) for the option and license agreement for novel antibodies for use in immuno-oncology therapeutics. It follows a recently announced corporate… This article is accessible to registered users, to continue reading please register for free . A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please  login . If your trial has come to an end, you can  subscribe here. • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results. • Daily roundup of key events in pharma and biotech. • Monthly in-depth briefings on Boardroom appointments and M&A news. • Choose from a cost-effective annual package or a flexible monthly subscription. If you are already a registered user please login . The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed Chairman, Sanofi Aventis UK

BioInvent International Frequently Asked Questions (FAQ)

  • When was BioInvent International founded?

    BioInvent International was founded in 1996.

  • Where is BioInvent International's headquarters?

    BioInvent International's headquarters is located at Soelvegatan 41, Lund.

  • What is BioInvent International's latest funding round?

    BioInvent International's latest funding round is IPO.

  • How much did BioInvent International raise?

    BioInvent International raised a total of $29.66M.

  • Who are the investors of BioInvent International?

    Investors of BioInvent International include Industrifonden and Sjatte AP-fonden.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.